These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19110675)

  • 1. Prevalence of cholelithiasis in a Turkish population of end stage renal failure patients and related risk factors: experience of a center from Turkey.
    Erten S; Erten AT; Ayli D; Köseoğlu T; Erten Y
    Turk J Gastroenterol; 2008 Jun; 19(2):139-40. PubMed ID: 19110675
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of gallstones in chronic renal failure patients undergoing hemodialysis: experience of a center in Turkey.
    Altiparmak MR; Pamuk ON; Pamuk GE; Celik AF; Apaydin S; Cebi D; Mihmanli I; Erek E
    Am J Gastroenterol; 2003 Apr; 98(4):813-20. PubMed ID: 12738461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of cholelithiasis in haemodialysis patients.
    Gladziwa U; Wagner S; Riehl J; Sieberth HG
    Nephrol Dial Transplant; 1993; 8(12):1397-400. PubMed ID: 8159315
    [No Abstract]   [Full Text] [Related]  

  • 4. [Are dialysis-patients a risk population for cholelithiasis? Study in an apulian population].
    Gernone G; Detomaso F; La Rosa R; Giannattasio M
    Minerva Urol Nefrol; 2009 Mar; 61(1):21-6. PubMed ID: 19417724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of biliary lithiasis in a Sicilian population of hemodialysis patients.
    Li Vecchi M; Cesare S; Soresi M; Arnone S; Renda F; Di Natale E; Figliola C; Li Vecchi V; Carroccio A; Montalto G
    Clin Nephrol; 2001 Feb; 55(2):127-32. PubMed ID: 11269676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of end stage renal failure by dialysis in Rhône-Alpes: changes over the period 1993-1999].
    Labeeuw M;
    Nephrologie; 2001; 22(4):161-6. PubMed ID: 11488170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in renal replacement therapy in Turkey, 1996-2008.
    Süleymanlar G; Serdengeçti K; Altiparmak MR; Jager K; Seyahi N; Erek E;
    Am J Kidney Dis; 2011 Mar; 57(3):456-65. PubMed ID: 21335249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystolithiasis in patients with end-stage renal disease treated with haemodialysis: a study of prevalence.
    Hojs R
    Am J Nephrol; 1995; 15(1):15-7. PubMed ID: 7872359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of depressive disorders in patients with end-stage renal failure].
    Makara-Studzińska M; Ksiazek P; Koślak A; Załuska W; Ksiazek A
    Psychiatr Pol; 2011; 45(2):187-95. PubMed ID: 21714208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholelithiasis in cirrhotic patients from Turkey.
    Ozyilkan E; Köseoglu T; Tatar G; Kayhan B; Telatar H
    Am J Gastroenterol; 1993 Jan; 88(1):155-6. PubMed ID: 8420266
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of a state data bank to measure incidence and prevalence of a chronic disease: end-stage renal failure.
    Brameld K; Holman D; Thomas M; Bass J
    Am J Kidney Dis; 1999 Dec; 34(6):1033-9. PubMed ID: 10585312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathy in United States long-term dialysis patients.
    Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
    Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and the characteristics of tuberculosis patients undergoing chronic dialysis treatment: experience of a dialysis center in southeast Turkey.
    Kayabasi H; Sit D; Kadiroglu AK; Kara IH; Yilmaz ME
    Ren Fail; 2008; 30(5):513-9. PubMed ID: 18569932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy.
    Merlino G; Piani A; Dolso P; Adorati M; Cancelli I; Valente M; Gigli GL
    Nephrol Dial Transplant; 2006 Jan; 21(1):184-90. PubMed ID: 16144846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemic of elderly patients with dialysis-requiring end-stage renal disease in New Zealand.
    Madhan K
    N Z Med J; 2004 Jun; 117(1195):U912. PubMed ID: 15282624
    [No Abstract]   [Full Text] [Related]  

  • 16. End-stage renal disease among living-kidney donors: single-center experience.
    Wafa EW; Refaie AF; Abbas TM; Fouda MA; Sheashaa HA; Mostafa A; Abo El Ghar MI; Ghoneim MA
    Exp Clin Transplant; 2011 Feb; 9(1):14-9. PubMed ID: 21605018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of risk factors for foot ulceration in patients with end-stage renal disease on haemodialysis.
    Kaminski M; Frescos N; Tucker S
    Intern Med J; 2012 Jun; 42(6):e120-8. PubMed ID: 21999812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of gallstone disease in patients with end-stage renal disease treated with hemodialysis in Korea.
    Hahm JS; Lee HL; Park JY; Eun CS; Han DS; Choi HS
    Hepatogastroenterology; 2003; 50(54):1792-5. PubMed ID: 14696406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher incidence of cholelithiasis in chronic renal failure patients with secondary hyperparathyroidism undergoing peritoneal dialysis.
    Barut I; Tarhan OR; Baykal B; Demir M; Celikbas B
    Ren Fail; 2007; 29(4):453-7. PubMed ID: 17497468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity and its change predict survival in incident dialysis patients.
    Miskulin DC; Meyer KB; Martin AA; Fink NE; Coresh J; Powe NR; Klag MJ; Levey AS;
    Am J Kidney Dis; 2003 Jan; 41(1):149-61. PubMed ID: 12500232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.